Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...
FDA decision puts pelareorep in focus Oncolytics Biotech (NasdaqCM:ONCY) is back on investor radars after the FDA granted Fast Track Designation to pelareorep in a combination regimen for second line ...
House Democrats have informed GOP leaders they will not help pass a funding package through a fast-track process, a source familiar with the matter confirmed to The Hill — complicating Speaker Mike ...